These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22540333)

  • 1. Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression.
    Dong L; Zhou Q; Zhang Z; Zhu Y; Duan T; Feng Y
    J Obstet Gynaecol Res; 2012 Aug; 38(8):1077-85. PubMed ID: 22540333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.
    Zhang Z; Dong L; Sui L; Yang Y; Liu X; Yu Y; Zhu Y; Feng Y
    Int J Gynecol Cancer; 2011 Feb; 21(2):213-21. PubMed ID: 21270604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expression.
    Jiang Y; Chen X; Wei Y; Feng Y; Zheng W; Zhang Z
    Biomed Pharmacother; 2019 May; 113():108712. PubMed ID: 30849641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on 'Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression'.
    Li W; Yang Y; Yan H
    J Obstet Gynaecol Res; 2013 Apr; 39(4):879. PubMed ID: 23379278
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to 'Comment on Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression'.
    Dong L; Zhou Q; Zhang Z; Zhu Y; Duan T; Feng Y
    J Obstet Gynaecol Res; 2013 Apr; 39(4):880. PubMed ID: 23379985
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
    Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
    Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma.
    Shibata K; Kikkawa F; Kondo C; Mizokami Y; Kajiyama H; Ino K; Nomura S; Mizutani S
    Gynecol Oncol; 2004 Nov; 95(2):307-13. PubMed ID: 15491750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel.
    Tseng SC; Huang YC; Chen HJ; Chiu HC; Huang YJ; Wo TY; Weng SH; Lin YW
    Biochem Pharmacol; 2013 Feb; 85(4):583-94. PubMed ID: 23228696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
    Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
    Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer.
    Luvsandagva B; Nakamura K; Kitahara Y; Aoki H; Murata T; Ikeda S; Minegishi T
    Gynecol Oncol; 2012 Jul; 126(1):132-9. PubMed ID: 22543280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of glyoxalase I and its effect on cell proliferation and apoptosis in endometrial carcinoma].
    Sui L; Guo QS; Zhang ZB; Jin HY; Yu YH; Feng YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):429-33. PubMed ID: 21029593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
    Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
    Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
    Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells.
    Rulli A; Antognelli C; Prezzi E; Baldracchini F; Piva F; Giovannini E; Talesa V
    Breast Cancer Res Treat; 2006 Mar; 96(2):187-96. PubMed ID: 16319983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glyoxalase I in the proliferation and apoptosis control of human LNCaP and PC3 prostate cancer cells.
    Antognelli C; Mezzasoma L; Fettucciari K; Mearini E; Talesa VN
    Prostate; 2013 Jan; 73(2):121-32. PubMed ID: 22653787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin: a potential novel endometrial cancer therapy.
    Mu N; Wang Y; Xue F
    Int J Gynecol Cancer; 2012 Feb; 22(2):181. PubMed ID: 22274313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.